Heat shock protein 70 is necessary to improve mitochondrial bioenergetics and
reverse diabetic sensory neuropathy following KU-32 therapy.
Authors Ma J, Farmer KL, Pan P, Urban MJ, Zhao H, Blagg BS, Dobrowsky RT
Submitted By Rick Dobrowsky on 6/2/2014
Status Published
Journal The Journal of pharmacology and experimental therapeutics
Year 2014
Date Published 2/1/2014
Volume : Pages 348 : 281 - 292
PubMed Reference 24263156
Abstract Impaired neuronal mitochondrial bioenergetics contributes to the
pathophysiologic progression of diabetic peripheral neuropathy (DPN) and may be
a focal point for disease management. We have demonstrated that modulating heat
shock protein (Hsp) 90 and Hsp70 with the small-molecule drug KU-32 ameliorates
psychosensory, electrophysiologic, morphologic, and bioenergetic deficits of DPN
in animal models of type 1 diabetes. The current study used mouse models of type
1 and type 2 diabetes to determine the relationship of changes in sensory neuron
mitochondrial bioenergetics to the onset of and recovery from DPN. The onset of
DPN showed a tight temporal correlation with a decrease in mitochondrial
bioenergetics in a genetic model of type 2 diabetes. In contrast, sensory
hypoalgesia developed 10 weeks before the occurrence of significant declines in
sensory neuron mitochondrial bioenergetics in the type 1 model. KU-32 therapy
improved mitochondrial bioenergetics in both the type 1 and type 2 models, and
this tightly correlated with a decrease in DPN. Mechanistically, improved
mitochondrial function following KU-32 therapy required Hsp70, since the drug
was ineffective in diabetic Hsp70 knockout mice. Our data indicate that changes
in mitochondrial bioenergetics may rapidly contribute to nerve dysfunction in
type 2 diabetes, but not type 1 diabetes, and that modulating Hsp70 offers an
effective approach toward correcting sensory neuron bioenergetic deficits and
DPN in both type 1 and type 2 diabetes.


Investigators with authorship
NameInstitution
Rick DobrowskyUniversity of Kansas Medical Center

Complications